Donaldson Company Inc
DCI
$84.48 0.27%
Exchange: NYSE | Sector: Industrials | Industry: Industrial Machinery
Q2 2025
Published: Mar 4, 2025

Earnings Highlights

  • Revenue of $870.00M down 0.8% year-over-year
  • EPS of $0.79 decreased by 2.4% from previous year
  • Gross margin of 35.2%
  • Net income of 95.90M
  • ""In January, we announced a partnership with Daimler Truck North America on their hydrogen fuel cell project. Donaldson's advanced air filter technology will be featured in the next generation Freightliner SuperTruck 2, solidifying our position at the forefront of hydrogen fuel cell innovation."" - Tod Carpenter

Donaldson Company Inc (DCI) QQ2 2025 Earnings Analysis: Margin Resilience and Growth Position in Filtration Technology Amid Currency Headwinds

Executive Summary

Donaldson Company’s second quarter of fiscal year 2025 (calendar Q2, ended Jan 31, 2025) delivered resilient gross margins and solid free cash flow despite modest revenue headwinds driven by currency and softer end markets. Reported revenue of $870 million declined 1% year over year, with currency a 170 basis point drag and a modest 1% pricing benefit, while gross margins remained strong at 35.2% and operating margins expanded 40 basis points to 15.2% on disciplined cost management. Management signaled continued leverage through a diversified, technology-led filtration portfolio, balance-sheet strength, and a disciplined investment posture aimed at sustaining long-term growth and margin expansion. Looking ahead, Donaldson maintained a constructive full-year outlook, guiding sales flat to up 4% and adjusted EPS of $3.60–$3.68, with operating margins targeting 15.6%–16.0% for the year. The company emphasized macro headwinds in agriculture and other end markets, along with potential tariff-related uncertainty, but highlighted strategic wins (e.g., hydrogen fuel-cell filtration technology with Daimler Truck North America) and accelerating connected-services growth as sources of upside. The outlook reflects a cautious-but-constructive stance: margin expansion is expected to ride operating leverage and ongoing cost discipline, while growth is anchored in aftermarket propelling share gains and select high-margin legacy and acquired businesses within Life Sciences and Industrial Solutions.

Key Performance Indicators

Revenue

870.00M
QoQ: -3.34% | YoY:-0.76%

Gross Profit

305.90M
35.16% margin
QoQ: -4.29% | YoY:0.36%

Operating Income

125.50M
QoQ: -4.05% | YoY:-3.24%

Net Income

95.90M
QoQ: -3.13% | YoY:-2.84%

EPS

0.80
QoQ: -3.61% | YoY:-2.44%

Revenue Trend

Margin Analysis

Key Insights

  • Revenue: $870.0 million, down 1% YoY; currency impact -170 bps; price impact +1% so ex-currency revenue +1% YoY
  • Gross margin: 35.16% (305.9/870.0); gross margin flat to prior year
  • Operating income: $125.5 million; operating margin 14.43% (125.5/870.0)
  • EBITDA: $155.9 million; EBITDA margin 17.93%
  • Net income: $95.9 million; net margin 11.02%

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 870.00 0.79 -0.8% View
Q1 2025 900.10 0.81 +6.4% View
Q4 2024 935.40 0.90 +6.4% View
Q3 2024 927.90 0.92 +6.0% View
Q2 2024 876.70 0.81 +5.8% View